# Boston Scientific

Organization · id `cardio:boston-scientific` · Cardiovascular Atlas · release `5dcd9b263fe17744` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Boston Scientific Corporation; Boston Scientific Corp

Browse, condition area: Heart rhythm problems  

## In plain language

A company. It is the applicant on the US approval of the WATCHMAN left atrial appendage closure device, and the lead sponsor of the PROTECT AF trial on the registry record.

## Technical summary

ClinicalTrials.gov NCT00129545 (PROTECT AF) lists Boston Scientific Corporation as lead sponsor, class INDUSTRY. The openFDA PMA record P130013 names Boston Scientific Corp as applicant. The abstract of the PROTECT AF paper names Atritech as funder; no source read explains how Atritech and Boston Scientific relate. ROR record 0385es521 lists Boston Scientific (United States) as a company and funder. Other products of the company are not covered here.

## Connected pages

- Manufactures: Subcutaneous ICD (S-ICD) system (`cardio:subcutaneous-icd`)
- Manufactures: WATCHMAN left atrial appendage closure device (`cardio:watchman`)
- Sponsors: PROTECT AF (`cardio:protect-af`)

## Provenance

Content hash: 80f808e50bd8a77d772cd9a3545234ea3c64c8c31e2348df08235ffda6e9263a
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-14